A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: The BELIEVE study

D. Thaçi*, J. P. Ortonne, S. Chimenti, P. D. Ghislain, P. Arenberger, K. Kragballe, J. H. Saurat, A. Khemis, P. Sprøgel, H. U. Esslinger, K. Unnebrink, H. Kupper

*Korrespondierende/r Autor/-in für diese Arbeit
79 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: The BELIEVE study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie